NCT06448611
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +19 more
- Locations
-
Not specified
Clinical trial condition
Merkel Cell Carcinoma
Explore clinical trials studying Merkel Cell Carcinoma. Study availability and eligibility vary by location and protocol.
68 public trials
19 recruiting studies
Merkel Cell Carcinoma trial results
Not Yet Recruiting
Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC)
NCT06086288
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- AOUS Policlinico Le Scotte Siena, Italy
- Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Italy
Not Yet Recruiting
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns
NCT06039033
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Power Life Sciences San Francisco, California, United States
NCT04157985
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT04242199
- Conditions
- Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Upmc Cancercenter Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center Houston, Texas, United States
Completed
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
NCT03783078
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
- Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
- Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
- Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
NCT02196961
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- University Hospital Essen, Dermatology Essen, North Rhine-Westphalia, Germany
- Charité Universitätsmedizin Berlin Berlin, Germany
- Elbeklinikum Buxtehude Buxtehude, Germany
- University Hospital Dresden, Dermatology Dresden, Germany
NCT02819843
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +21 more
- Locations
-
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT04160065
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT03629756
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
- Locations
-
- Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
- University of California, Los Angeles Los Angeles, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States